Pfizer reported another quarter of huge revenues growth because of its COVID-19 vaccine on Tuesday, but lowered the company's full-year profit forecast due in part to shifts in foreign exchange.
The major American drugmaker reported revenues of $25.7 billion for the first quarter, up 77 percent from the year-ago period, with the COVID vaccine taking in $13.2 billion.
Net income jumped 61% to $7.9 billion.
More HERE
By Illinois ReviewWith control of Congress on the line in less than a month, Naples-based Chicago radio host Dan Proft spent part of Tuesday’s broadcast welcoming John Bolton,...
Read moreDetails
By Mark Weyermuller, Opinion Contributor & PhotojournalistErika Kirk spoke Tuesday at Judson University in Elgin, Illinois, as part of Turning Point USA’s “America: Love It or Leave It”...
Read moreDetails
By Illinois ReviewFormer Illinois House Republican Leader Jim Durkin endorsed Democratic Gov. JB Pritzker for a third term Monday, breaking with Republican nominee Darren Bailey while working with...
Read moreDetails
By Jacqueline Garretson, Opinion ContributorIt has been more than five years since COVID-19 changed our lives, but for many Illinois families, the consequences never really went away. Businesses...
Read moreDetails
By Shannon AdcockPresident, Awake Illinois & Opinion Contributor Illinois ranks next to last on whether its public schools put students and parents first. That is the finding of...
Read moreDetails
llinois Review LLC Editor-in-Chief Mark Vargas General Counsel Scott Kaspar Copyright © 2025 IR Media Corp., all rights reserved.